Search All News
By learning how contagious cancer spreads among shellfish, scientists hope to better understand how cancer metastasizes in people.
Researchers at Columbia are tackling cancer disparities in northern Manhattan and surrounding areas through the National Cancer Institute’s network of community-based research programs.
Columbia oncologists are bringing their latest techniques in precision medicine to veterans with advanced prostate cancer.
Katherine Crew, MD, directs the Clinical Breast Cancer Prevention Program and cares for patients with breast cancer and women at high risk at Columbia University Irving Medical Center/NYP.
- July 21, 2016
Adding a new drug called olaratumab to traditional chemotherapy increased survival in sarcoma patients, researchers at Columbia University Medical Center have found.
- July 15, 2016
The three-dimensional structure could help researchers develop novel therapies and diagnostic tools for diseases that are caused by a malfunction in calcium adsorption.
- July 12, 2016
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
- July 8, 2016
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
- July 1, 2016
CUMC, NYP, and Weill Cornell are participating in a care delivery model that supports and encourages higher quality, more coordinated cancer care.
Source:The New York TimesJune 23, 2016
- June 22, 2016
New research suggests that direct transmission of cancer among marine animals may be much more common than once thought.
- June 22, 2016
Cancer centers announce the establishment of a research consortium focused on accelerating the discovery and development of novel cancer therapeutics and diagnostics for the benefit of patients.
- June 16, 2016
One out of four breast cancer patients skipped hormonal therapy if they previously avoided treating chronic conditions, Columbia researchers found.
- March 31, 2016
An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA levels who had more aggressive disease.